MedTrace Logo

SITS-IVT in Patients >80 Years Study

NCT04260347 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1655

Last updated 2024-07-05

Study results available
· View outcomes & findings →

Summary

A non-interventional post-approval study on Safe Implementation of Treatment in Stroke - International Stroke Thrombolysis Register (SITS-ISTR) existing data of intravenous recombinant tissue plasminogen Activator (rt-PA) (0.9 mg/kg) in acute ischaemic stroke patients over 80 years, treated according to the Summary of Product Characteristics (SmPC) in European countries.

Conditions

  • Ischaemic Stroke

Interventions

DRUG

Alteplase

Intravenous injection

Sponsors & Collaborators

Eligibility

Min Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-14
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04260347 on ClinicalTrials.gov